Skip to main content
Leif Ellisen, MD, Oncology, Boston, MA

LeifWilliamEllisenMDPhD

Oncology • Boston, MA

Professor of Medicine, Massachusetts General Hospital and Harvard Medical School

Join to view full profile

Dr. Ellisen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ellisen's full profile

Already have an account?

  • Office

    55 Fruit St
    Grj 904
    Boston, MA 02114
    Phone+1 617-724-1399
    Fax+1 617-726-8623

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1994
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1992

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1994 - 2025

Publications & Presentations

PubMed

Press Mentions

  • Mechanisms of Resistance to Drug for Triple-Negative Breast Cancer Identified
    Mechanisms of Resistance to Drug for Triple-Negative Breast Cancer IdentifiedAugust 17th, 2021
  • Researchers Identify Mechanisms of Resistance to Drug for Triple-Negative Breast Cancer
    Researchers Identify Mechanisms of Resistance to Drug for Triple-Negative Breast CancerAugust 17th, 2021
  • Scientists Discover How Triple-Negative Breast Cancer Can Defeat Powerful Drugs
    Scientists Discover How Triple-Negative Breast Cancer Can Defeat Powerful DrugsAugust 16th, 2021
  • Join now to see all

Grant Support

  • P63 Mechanisms And Mediators In HnsccNational Institute Of Dental &Craniofacial Research2011
  • Function And Mechanism Of REDD1 Signaling To TSC1/2 And MTORC1National Cancer Institute2007–2011
  • P63 Mediators As Therapeutic Targets In HnsccNational Institute Of Dental &Craniofacial Research2004–2010
  • Telomerase Functions In Differentiation &TransformationNational Cancer Institute1999–2003

Dr. Leif Ellisen, Dr. Leif Ellisen, MD, Dr. L Ellisen, Dr. Leif William Ellisen